Atypical Haemolytic Uremic Syndrome (aHUS) is such a condition, rare, complex, and often misdiagnosed as other diseases. It strikes only a few individuals globally, but its effect can be life ...

Health Canada has approved Novartis Canada’s Fabhalta (iptacopan capsules) as the first oral monotherapy to treat adults with paroxysmal nocturnal haemoglobinuria (PNH) and haemolytic anaemia.

Little Harry and Archie share a rare condition which means they face a lifetime of infusion treatments ahead — but with their ...